Large delta antigen (L-HDAg) of hepatitis delta virus (HDV) and small-form hepatitis B surface antigen (HBsAg) of helper hepatitis B virus have previously been shown to be the minimum components for the assembly of HDV-like particles in mammalian cells. Extending from this finding, we coexpressed L-HDAg and small HBsAg in Saccharomyces cerevisiae to study their assembly in yeast cells. The assembly of virus particles from L-HDAg and HBsAg in yeast was demonstrated by their coexistence in the same isopycnic fractions and by the coimmunoprecipitation of L-HDAg with HBsAg using an antibody against HBsAg (anti-HBs). Furthermore, after purification by affinity chromatography with anti-HBs, HDV-like particles with size and morphology similar to those derived from mammalian cells could be visualized by electron microscopy. Mice immunized with yeast-derived HDV-like particles simultaneously acquired antibodies against HBsAg and HDAg, indicating that both viral proteins are antigenic. The results indicated that S. cerevisiae could serve as a host for the assembly of HDV-like empty particles. This system may be useful in investigating cellular processes involved in HDV assembly and in producing ample amount of HDV-like particles for structural and immunological studies. ᭧ 1997 Academic Press
.
Hepatitis delta virus (HDV) is a defective human patho-
Since the host range of hepadnaviruses, and hence gen causing severe acute liver inflammation or progresthe HDV, is very restricted, tissue culture cells have been sive chronic liver diseases (Rizzetto and Verme, 1985) . It a convenient system for the study of the assembly of requires a hepadnavirus helper, the human hepatitis B HDV. Cotransfection of HBV-and HDV-expressing plasvirus (HBV) or the woodchuck hepatitis B virus, to provide mids into mammalian cell lines has yielded HDV particles envelope proteins for virion assembly and transmission in vitro (Wu et al., 1991; Ryu et al., 1992) . Furthermore, (Rizzetto et al., 1980; Ponzetto et al., 1984) .
L-HDAg along with the small form of HBsAg is necessary The virion of HDV is a 36-nm particle, with an envelope and sufficient for the assembly of HDV-like particles decomposed of lipid coat and three forms of hepatitis B void of viral RNA (Chang et al., 1991; Wang et al., 1991; virus surface antigen (HBsAg) (Bonino et al., 1986; He et Ryu et al., 1992) . On the other hand, S-HDAg alone can al., 1989), termed large, middle, and small HBsAg acnot interact with HBsAg and thus will not be packaged cording to their protein sizes (Ganem and Varmus, 1987) .
into particles. Nevertheless, it can be copackaged Inside the envelope is the 1.7-kb circular RNA genome through protein-protein interactions with L-HDAg (Chen and two forms of HDV-specific proteins, namely the small et al., 1992). (24 kDa) and the large (27 kDa) delta antigens (S-and Although HDV can be assembled in mammalian cells, L-HDAg) (Bonino et al., 1986; Kos et al., 1986; mass production of HDV particles using this system is al., 1986). L-HDAg is identical to S-HDAg except that not practical. Since HBsAg particles can be assembled it contains a 19-amino-acid extension at the carboxyl in yeast (Valenzuela et al., 1982; Hitzeman et al., 1983 ) terminus as a result of an RNA editing event which elimibut not in bacteria (Edman et al., 1981; Mackay et al. , nates the termination codon of S-HDAg (Luo et al., 1990) .
1981), we explored the possibility of using yeast, SacAlthough sharing similar biochemical properties, these charomyces cerevisiae, as an alternative host for the astwo proteins play different roles in the viral life cycle. Ssembly of HDV-like particles. The yeast expression sysHDAg is required for HDV RNA replication (Kuo et al., tem has been used successfully not only for the assem-1989), whereas L-HDAg inhibits the replication and is bly of HBsAg particles but also for that of the HBV-like particles (Shiosaki et al., 1991) and the L1, L2-containing particles of human papillomavirus (Hofmann et al., 1995) .
lishment of yeast as an alternative host for the assembly Transfection of DNA of HDV-like particles would make large-scale production Transfection of HuH-7 cells was performed by the calof these particles possible. These particles can then cium phosphate precipitation method as described preserve many purposes, such as immunological and strucviously (Wu et al., 1991) . tural studies.
In this communication, we report the coexpression of Transformation of plasmid DNA into yeast cells L-HDAg and HBsAg in yeast and the assembly of these two proteins into HDV-like particles as characterized by Plasmid DNA was introduced into yeast using lithium isopycnic centrifugation, coimmunoprecipitation, and chloride according to the methods developed previously electron microscopy.
with some modifications (Gietz et al., 1992) . To coexpress two proteins in a yeast cell, pGAD/L-HDAg or pGAD/SHDAg was cotransformed with pGPD/S into yeast cells
MATERIALS AND METHODS
and the cotransformants were selected in SD synthetic medium lacking leucine and tryptophan. 10-fold volume of YEPD medium (1% yeast extract, 2% gal 4-542, gal 80-538, URA 3::GAL 1-lac Z) was purpeptone, 2% glucose), and cultured at 30Њ to midlog chased from Clontech (Palo Alto, CA) and used as a host phase or for about 20 hr for large-scale preparation. Cells cell for the expression of viral proteins.
were collected by centrifugation (2000 g, 5 min), resuspended in P i /NaCl (10 mM sodium phosphate, 0.85% Plasmids NaCl) with 0.1% Triton X-100, and broken by 1 min of vigorous vortexing with glass beads (0.45-0.60 mm; Plasmid pSVDAg-L (Chang et al., 1991 ) is a mammalian Sigma, St. Louis, MO) four times with intermittent cooling vector expressing L-HDAg. pSX-N is a derivative of on ice or in Dyno Mill KDL (Batch) (3000 rpm, 8 min). The pDPSX . The consensus motif for Nlysates were clarified by centrifugation at 10,000 g for 10 linked glycosylation in pSX-N has been mutated, so that min at 4Њ and the supernatants were collected for analyit expresses only the unglycosylated form of small HBsAg sis or further purification. in mammalian cells (Wang et al., 1996) .
To construct and express proteins of interest in yeast, Immunoblot analysis and immunoprecipitation of two cloning vectors, pGPD (for HBsAg) and pGAD424 proteins (Clontech) (for S-HDAg and L-HDAg) were used. They are yeast S. cerevisiae-E. coli shuttle vectors containing Aliquots of protein extracts from transformed cells were subjected to electrophoresis on 12% polyacrylpromoters of yeast genes (the glyceraldehyde-3-phosphate dehydrogenase gene promoter in pGPD and the amide gels. The gels were either stained by BM fast staining (Boehringer Mannheim) for total protein detecalcohol dehydrogenase gene promoter in pGAD424). They also carry different nutritional genes (TRP 1 in pGPD tion or transferred electrophoretically to a nitrocellulose filter (Hybond-C; Amersham, Buckinghamshire, UK) and and LEU 2 in pGAD424) that allow yeast auxotrophs to grow on synthetic media lacking tryptophan or leucine. subjected to immunoblotting as described before (Chang et al., 1991; Wang et al., 1996) . For the construction of pGPD/S (Fig. 1A ) expressing small HBsAg in yeast, a 962-bp EcoRI-HpaI fragment of HBV Immunoprecipitations were performed with either antiHBs (1:300 dilution) or anti-HDAg (1:500). Transformed DNA was blunted with the Klenow fragment of DNA polymerase I and subcloned into pGPD that had been treated yeast cells were grown and disrupted, as described in the previous section, in immunoprecipitation buffer (50 with XhoI plus EcoRI and blunted with the Klenow fragment. To express S-HDAg and L-HDAg, DNA fragments mM Tris-HCl, pH 8.0, 150 mM NaCl, 5 mM EDTA, and 0.1% Triton X-100). Protein extracts were incubated with containing S-or L-HDAg open reading frame were generated from pSVDAg-S (Kuo et al., 1989) or pSVDAg-L the specific antibody for 60 min, followed by addition of 30 ml of a 50% protein G-conjugated agarose for another (Chang et al., 1991) by either ScaI plus SalI or ScaI plus PstI digestion. Both fragments were blunted and sub-60 min. The precipitate was washed three times with the same buffer and antigen-antibody complexes were cloned into a modified pGAD424 from which the 680-bp HindIII-HindIII fragment had been deleted to remove eluted from the agarose beads by boiling in 11 Laemmli loading buffer (0.0625 M Tris-HCl, pH 6.8, 2% SDS, 10% the GAL4-DNA-activation domain, and the resultant ends were filled in with the Klenow fragment. The resulting v/v glycerol, 0.1 M DTT) for 5 min. The eluted products were then examined by immunoblotting with anti-HDAg plasmids were designated pGAD/S-HDAg and pGAD/LHDAg, respectively (Fig. 1A) .
or anti-HBs antibody. Cesium chloride gradient analysis of yeast lysates centrifuged in an SW 28 rotor at 25,000 rpm, 4Њ for 16 hr. The pellets were resuspended in 100 mM phosphate The clarified lysates of transformed cells were layered buffer (pH 8.0) and then loaded onto a column of Sephon a 20% sucrose cushion and then centrifuged in an arose 4B conjugated with mouse anti-HBs antibody. SW 28 (Model L-8 M; Beckman) rotor at 25,000 rpm for
The absorbed antigens (and particles) were eluted with 16 hr. The pellet was dissolved in 0.5 ml P i /NaCl, layered 3 M sodium thiocyanate/0.1 M sodium chloride, then onto a discontinuous cesium chloride gradient (1.1-1.4 desalted and concentrated by a Centricon-30 (Amicon, g/cm 3 ), and centrifuged at 35,000 rpm in an SW 41 rotor Beverly, MA). for 24 hr. Fractions of 0.5 ml were collected from the Samples purified from affinity chromatography were bottom, diluted with five volumes of P i /NaCl, and centrinegatively stained with 2% potassium phosphotungstic fuged in a TLA 100.3 rotor (TL-100; Beckman) at 60,000 acid and examined by electron microscopy (Hitachi, rpm for 2 hr, and the resulting pellets were resuspended H7100). in P i /NaCl. The presence of HBsAg and HDAg in each fraction was then assayed by immunoblotting.
Expression and purification of recombinant S-HDAg in E. coli Affinity chromatography and electron microscopy
The clarified protein extract of transformed cells or
The HDV cDNA fragment from nucleotides 1598-1012 was amplified by polymerase chain reaction and subculture supernatant from transfected HuH-7 cells was cloned into a pET15a vector (Novagen, Madison, WI). The resulting plasmid was transformed into E. coli BL21(DE3) to express a recombinant S-HDAg having Nterminal His-Tag by induction with 1 mM isopropyl-b-D-thiogalactopyranoside. The recombinant S-HDAg was purified by affinity chromatography with a nickel column (Novagen) and then continuous elution gel electrophoresis (Prep Cell, Model 491; Bio-Rad, Hercules, CA) as described in the manufacturer's instructions.
Immunization of mice and assay of antibodies
Six-week-old female Balb/c mice were injected with one of the following antigens: (i) 20 mg protein extract from untransformed yeast cells; (ii) affinity-purified HDVlike empty particles in different amounts: one contained 400 ng HBsAg and 20 ng L-HDAg and the other contained 200 ng HBsAg and 10 ng L-HDAg; or (iii) 1 mg purified recombinant S-HDAg derived from E. coli. Antigens were emulsified with complete Freund's adjuvant and inoculated into the mice intraperitoneally. The mice were boosted once with the same antigen preparations in incomplete Freund's adjuvant 4 weeks later. Serum specimens were collected on day 14 after the booster and assayed for specific antibodies.
The murine serum specimens were diluted in 1:100 to detect anti-HBs by a commercial enzyme immunoassay kit (Ausab EIA Diagnostic Kit; Abbott Laboratories, North Chicago, IL). Antibody to HDAg was assayed by enzymelinked immunosorbent assay (ELISA) with purified HDAg following standard procedures. Recombinant S-HDAg purified from E. coli was adsorbed to wells of a microtiter plate at a concentration of 5 mg/ml (100 ml/well) in carbonate coating buffer (60 mM Na 2 CO 3 , 35 mM NaHCO 3 , pH 9.6) at 4Њ overnight. Mouse sera at 1:100 dilution were added to the wells and incubated at 37Њ for 2 hr. (Fig. 1C, lane 1) or S-HDAg and HBsAg (lanes 2 in Figs. yeast cells 1B and 1C) were expressed in cotransformed cells. Consistent with previous reports, only a single band correTo examine whether yeast S. cerevisiae can serve as an alternative host for HDV assembly, we first coexsponding to the size of unglycosylated small HBsAg was detected (Valenzuela et al., 1982; Hitzeman et al., 1983) , pressed L-HDAg and small HBsAg in yeast cells. Yeast cells were cotransformed with either pGPD/S and pGAD/ indicating that most molecules of the small HBsAg in yeast were not glycosylated. No signal was detected in L-HDAg or pGPD/S and pGAD/S-HDAg (as a negative control for the assembly) and selected in synthetic media extracts derived from untransformed yeast cells (lanes 3, Figs. 1B and 1C ). For comparison, lysates from HuHlacking tryptophan and leucine for cotransformants. Lysates from cells growing on selective media were then 7 cells cotransfected with plasmids expressing L-HDAg (pSVLDAg-L) and unglycosylated form of small HBsAg assayed for the presence of HBsAg and HDAg by immunoblot analysis. Both L-HDAg (Fig. 1B, lane 1) and HBsAg (SX-N) were also analyzed (lanes 4 in Figs. 1B and 1C) . , suggesting that S-HDAg alone was not packstudies (Valenzuela et al., 1982; Hitzeman et al., 1983) . aged into HBsAg particles, similar to the finding in the mammalian system. In contrast, HBsAg could not be preCharacterization and electron microscopic study of cipitated with anti-HDAg (Fig. 3B , bottom, lane 2), sugparticles purified from yeast gesting that packaged L-HDAg was inside the HBsAg To examine whether HBsAg and L-HDAg can be asparticles and thus could not interact with anti-HDAg antisembled into HDV-like empty particles in yeast, crude body. However, L-HDAg from cotransformed yeast cells extracts from cotransformed yeast cells were subjected could still be immunoprecipitated by anti-HDAg antibody to CsCl equilibrium centrifugation. After centrifugation, (Fig. 3B , top, lane 2), implying that not all L-HDAg was fractions were collected and each was assayed for the inside the particles. These free forms of L-HDAg may presence of specific proteins by immunoblotting. As result from the unassembled L-HDAg or from disruption shown in Fig. 2A , in the extracts from cells cotransformed of particles during the protein extraction process. with pGPD/S and pGAD/L-HDAg, HBsAg and L-HDAg Isoprenylation of L-HDAg at the C terminus has been were found in the same isopycnic fractions (fractions 12-shown to be indispensable for the interactions between 13) with a density of around 1.20 g/cm 3 . It appears that L-HDAg and HBsAg and hence the formation of HDV fraction 14 contained only HBsAg, suggesting that most particles (Glenn et al., 1992; Hwang and Lai, 1993) . Asof the particles in this fraction were empty HBsAg partisembly of HDV-like particles in yeast as we have recles. The buoyant density of fraction 14 is approximately ported here implied that L-HDAg synthesized in yeast 1.18 g/cm 3 , consistent with the previously reported rewas isoprenylated. Yeast farnesyltransferase (FTase) sults of the serum-and yeast-derived empty HBsAg partihas been known to be biochemically similar to mammacles (Hitzeman et al., 1983) . As a control (Fig. 2B) , only lian FTase (Omer and Gibbs, 1994) which farnesylates HBsAg, and no S-HDAg, could be detected in the isopycHDAg in vitro and in animal cells (Otto and Casey, 1996) . nic fractions around 1.20 g/cm 3 in the extracts from cells Furthermore, our results also suggested that, like in the cotransformed with pGPD/S and pGAD/S-HDAg.
RESULTS AND DISCUSSION

Coexpression of HBsAg and L-HDAg or S-HDAg in
case of HBsAg particle formation (Valenzuela et al., To further demonstrate that L-HDAg is indeed assem-1982), glycosylation of HBsAg is not essential for the bled into HBsAg particles in yeast, coimmunoprecipitaformation of HDV-like particles. The observations are tion assay was performed. Protein extracts from cells consistent with our recent results in human hepatoma cotransformed with either pGPD/S and pGAD/L-HDAg or cell lines (Wang et al., 1996) . Yeast-derived HBsAg-containing proteins purified by afpGPD/S and pGAD/S-HDAg were first immunoprecipi- Histograms of the size distribution of particles, which were generated by measuring the diameters of 100 intact particles observed in representative fields. The particle diameter was inferred assuming that the particles were perfect spheres. finity chromatography of anti-HBs antibody were examined by electron microscopy for HDV-like particles. Particles with diameters ranging from 20 to 37 nm were present in samples purified from yeast cells cotransformed with pGPD/S and pGAD/L-HDAg. Figure 4A shows that these particles could be divided into two populations; the major one is smaller than 30 nm and peaked at 20-25 nm; the other is larger than 30 nm and peaked around 37 nm (arrowheads indicate representative particles). The size distribution of particles purified from yeast was compared to that purified from HuH-7 cells transfected with L-HDAg-and nonglycosylated small HBsAg-expression vectors. The patterns appear to be very similar (compare Figs. 4A and 4B ). In contrast, particles purified from pGPD/S-and pGAD/S-HDAgcotransformed yeast cells, which should consist of HBsAg particles only, revealed only a major population peaking at 20-22 nm; no particles larger than 30 nm were observed (Fig. 4C) . The size distribution of these particles is reminiscent of the reported HBsAg particles in yeast (Petre et al., 1987) . We presumed that the particles with sizes around 37 nm, similar to the size of the natural virion (He et al., 1989) , were HDV-like particles, and those with sizes around 22 nm were most likely HBsAg particles.
Calculating the exact proportion of HDV-like particles in yeast lysates was difficult due to the lack of satisfactory methods to separate HDV-like and HBsAg empty particles and also the uncertainty regarding the molar ratio of HBsAg to L-HDAg in an HDV-like empty particle. However, by electron microscopic observation, HDV-like particles were roughly estimated to constitute about 5-10% of total particles in both yeast and mammalian preparations. By SDS-PAGE analysis, the ratio of L-HDAg to malian cell-derived particles, respectively. The packaging efficiency of HDV-like empty particles in yeast system thus appears to be similar to that in mammalian cells.
ing susceptible woodchucks or chimpanzees with recombinant S-HDAg may limit the level of hepatitis D Induction of antibodies to both HBsAg and HDAg by viremia, but failed to protect the animals (Kos et al., 1991; HDV-like empty particles from yeast Karayiannis et al., 1993) . However, the recombinant HDAg used in previous studies were all free polypepThe immunogenicity of yeast-derived HDV-like empty tides. As intact HBsAg particles have been known to be particles was tested in mice. Sera of the mice immunized more immunogenic than free proteins (Cabral et al., with yeast-derived HDV-like particles were demonstrated 1978), HDAg in particle forms may also yield a better to contain antibodies against both HDAg and HBsAg by immunogenicity. Our results in mice indicated that the ELISA (Fig. 5) . The specificity of these antibodies was yeast-derived HDV-like particles were quite immunoconfirmed by immunoblot analysis (data not shown). As genic. Thus, the successful assembly of HDV-like partia control, mice immunized with either purified S-HDAg cles in yeast may be used for the production of large from E. coli lysates or crude extracts of untransformed amounts of these particles for further studies in susceptiyeast cells produced antibody against HDAg only or no ble animals, such as woodchucks, to examine their imantibody against HDAg and HBsAg, respectively (Fig. 5) . munogenicity and protective efficacy as a potential vacThe results indicated that the yeast-derived HDV-like parcine. ticles were immunogenic in eliciting humoral immunity against both HDAg and HBsAg in mice. ACKNOWLEDGMENTS HDAg is the only known protein causing antibody responses after an HDV infection, but the role of this antiWe thank Dr. S. C. Lee (Graduate Institute of Molecular Medicine, College of Medicine, National Taiwan University, Taipei) for providing body in protecting against HDV is still not clear. Immuniz-
